3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A cross-sectional survey on the rate of awareness of hepatitis B virus (HBV) infection and the prevention of mother-to-child transmission among hepatitis B surface antigen (HBsAg)-positive pregnant women

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Mother-to-child transmission (MTCT) remains the main transmission route of hepatitis B virus (HBV) in China. Hepatitis B surface antigen (HBsAg) positive pregnant women were the main participants in MTCT of HBV. Nevertheless, little was known about their knowledge and awareness of HBV infection and MTCT. We intended to evaluate their knowledge of HBV infection and MTCT prevention, and to clarify the emphasis of health education to improve the control of MTCT of HBV.

          Methods

          We invited 164 HBsAg-positive pregnant women, who were aged ≥18 years old, had basic literacy skills and visited the Outpatient Clinic of Infectious Disease of the Sun Yat-Sen Memorial Hospital from May 2019 to January 2020, to independently and anonymously complete a self-administered survey regarding their knowledge of HBV infection and MTCT prevention. The correct rate of the questions was calculated and analyzed. A multivariate regression was conducted to identify predictors of HBV and MTCT knowledge and awareness.

          Results

          The average awareness rate of the 164 respondents was 52.56%, among which the awareness rates of basic knowledge and the transmission route of HBV were 80.49% and 53.29%, respectively. The awareness rates of knowledge about the interruption measures of MTCT during pregnancy, delivery, and postpartum were 43.78%, 49.75%, and 31.25%, respectively. The respondents who had a college education level or above, were employed, and had visited the outpatient Department of Infectious Disease before pregnancy had a significantly higher awareness rate. Previous visits to the Department of Infectious Disease were the only influencing factor for the higher awareness rate (OR =3.108, P=0.049).

          Conclusions

          A lack of knowledge about the transmission route and interruption measures of MTCT of HBV is still common among HBsAg-positive pregnant women. Health education should be directed toward HBsAg-positive mothers to further improve the control of HBV infection.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

          The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmission make elimination of HBV feasible. We aimed to estimate the national, regional, and global prevalence of HBsAg in the general population and in the population aged 5 years in 2016, as well as coverage of prophylaxis, diagnosis, and treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Countdown to 2030: eliminating hepatitis B disease, China

            Abstract Hepatitis B virus (HBV) infection is a major public health problem worldwide. China has the world’s largest burden of HBV infection and will be a major contributor towards the global elimination of hepatitis B disease by 2030. The country has made good progress in reducing incidence of HBV infection in the past three decades. The achievements are mainly due to high vaccination coverages among children and high coverage of timely birth-dose vaccine for prevention of mother-to-child transmission of HBV (both > 95%). However, China still faces challenges in achieving its target of 65% reduction in mortality from hepatitis B by 2030. Based on targets of the World Health Organization’s Global health sector strategy on viral hepatitis 2016–2021, we highlight further priorities for action towards HBV elimination in China. To achieve the impact target of reduced mortality we suggest that the service coverage targets of diagnosis and treatment should be prioritized. First, improvements are needed in the diagnostic and treatment abilities of medical institutions and health workers. Second, the government needs to reduce the financial burden of health care on patients. Third, better coordination is needed across existing national programmes and resources to establish an integrated prevention and control system that covers prevention, screening, diagnosis and treatment of HBV infection across the life cycle. In this way, progress can be made towards achieving the target of eliminating hepatitis B in China by 2030.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].

              (2019)
              Based on the progression of clinical and basic research in hepatitis B virus (HBV), we updated the previous HBV guidelines from 2015. The guidelines included the prevention, diagnosis, and antiviral therapy of chronic hepatitis B, which accelerates ro achieve the goal of "the elimination of viral hepatitis as a public health threat by 2030" proposed by the World Health Organization.
                Bookmark

                Author and article information

                Journal
                Ann Transl Med
                Ann Transl Med
                ATM
                Annals of Translational Medicine
                AME Publishing Company
                2305-5839
                2305-5847
                July 2022
                July 2022
                : 10
                : 14
                : 773
                Affiliations
                [1 ]deptEmergency Department, Sun Yat-sen Memorial Hospital , Sun Yat-sen University , Guangzhou, China;
                [2 ]deptDepartment of Infectious Disease, Sun Yat-sen Memorial Hospital , Sun Yat-sen University , Guangzhou, China;
                [3 ]deptDepartment of Gastroenterology, Sun Yat-sen Memorial Hospital , Sun Yat-sen University , Guangzhou, China;
                [4 ]deptOutpatient Office, Sun Yat-sen Memorial Hospital , Sun Yat-sen University , Guangzhou, China;
                [5 ]Central Injection Room, deptSun Yat-sen Memorial Hospital , Sun Yat-sen University , Guangzhou, China
                Author notes

                Contributions: (I) Conception and design: X Min, Z Huang; (II) Administrative support: X Min, Z Ou; (III) Provision of study materials or patients: X Min, T Liu; (IV) Collection and assembly of data: Z Huang, J Chen, T Liu; (V) Data analysis and interpretation: Y Qin, Z Huang, T Liu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

                [#]

                These authors contributed equally to this work.

                Correspondence to: Xiaohui Min. Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, Yanjiangxi Road, Guangzhou 510120, China. Email: minxh@ 123456mail.sysu.edu.cn .
                Article
                atm-10-14-773
                10.21037/atm-22-2748
                9372653
                35965787
                3b3fcba4-059b-412d-a9a4-53066e543a62
                2022 Annals of Translational Medicine. All rights reserved.

                Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

                History
                : 27 April 2022
                : 30 June 2022
                Categories
                Original Article

                hepatitis b surface antigen-positive pregnant women (hbsag-positive pregnant women),hepatitis b,mother-to-child transmission (mtct),knowledge,awareness rate

                Comments

                Comment on this article